Sociedad Americana de Hirudoterapia

Complete mitochondrial genome of Hirudo nipponia (Annelida, Hirudinea)

Genome resource published in Mitochondrial DNA A (2014)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genómica y proteómicaYan H et al. · Mitochondrial DNA, 2014

Abstract

The complete mitochondrial genome (14,414 bp) of the blood-feeding leech Hirudo nipponia, which was an important natural medicinal resource, was sequenced and characterized. The genome encodes 13 protein-coding genes, 2 rRNAs and 22 tRNAs. The content of A + T was 72.60% for H. nipponia (31.69% A, 40.91% T, 15.45% G and 11.95% C). All protein-coding genes started with ATN except for nad3 and nad5, which used GTG as start codon. Eight protein-coding genes stopped with termination codon TAA. Five protein-coding genes used incomplete stop codon TA or T. The A + T-rich region was located between tRNA-Arg and tRNA-His with a length of 83 bp. This is the first report about completely sequenced mitochondrial genome from the family Hirudinidae. The complete mitochondrial genomes of H. nipponia would be useful for the exploration of Hirudinea polygenetic relationships.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsGenes, rRNAGenome, MitochondrialLeechesMolecular Sequence AnnotationMolecular Sequence DataOpen Reading FramesPhylogenyRNA, TransferSequence Analysis, DNA

Resumen

First complete mitochondrial genome (14,414 bp) of the blood-feeding medicinal leech Hirudo nipponia. Encodes 13 protein-coding genes, 22 tRNAs, and 2 rRNAs, with characterization of structural and phylogenetic features.

Por qué esto importa para la hirudoterapia

Reference mitogenome for an East-Asian medicinal-leech species — foundational omics data.

Citación

Complete mitochondrial genome of Hirudo nipponia (Annelida, Hirudinea).

Yan H et al. · Mitochondrial DNA, 2014

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.